New reports detail the spread of SARS-CoV-2 variant BA.3.2, Long COVID disability burden, sarbecovirus cross-immunity, and how stacked outpatient risk factors shape severe COVID-19 outcomes.
This roundup explores updated 2024-2025 COVID-19 vaccine effectiveness data, an FDA-cleared 4-pathogen home test, and new evidence on metformin for long COVID risk.
A large multinational cohort study evaluated whether COVID-19 vaccination during pregnancy reduces the risk of preeclampsia, a major hypertensive complication associated with SARS-CoV-2 infection.
Maternal COVID-19 vaccination was linked with fewer severe maternal outcomes; early mRNA vaccination showed no rise in malformations; in utero infection was tied to higher neurodevelopmental diagnoses.
...
Emerging data identify molecular subtypes of Long COVID, link pediatric disease to school absenteeism, and define occupational risk factors for persistent symptoms.
A new national analysis estimates the burden of COVID-19–associated illnesses, outpatient visits, hospitalizations, and deaths in the United States from October 2022 through September 2024, offering...
A cohort study published in JAMA Network Open evaluates whether establishing state medical operations coordination centers was associated with changes in interhospital transfer rates during occupancy stress...
